Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Javier Garde-Noguera"'
Autor:
Miguel Sampayo-Cordero, Bernat Miguel-Huguet, José Pérez-García, David Páez, Ángel L. Guerrero-Zotano, Javier Garde-Noguera, Elena Aguirre, Esther Holgado, Elena López-Miranda, Xin Huang, Andrea Malfettone, Antonio Llombart-Cussac, Javier Cortés
Publikováno v:
Contemporary Clinical Trials Communications, Vol 20, Iss , Pp 100678- (2020)
Introduction: Non-inferiority (NI) analysis is not usually considered in the early phases of clinical development. In some negative phase II trials, a post-hoc NI analysis justified additional phase III trials that were successful. However, the risk
Externí odkaz:
https://doaj.org/article/9bb5f763d2cb4e348ebf7d6ca9bbebc7
Autor:
Javier, Garde-Noguera, Margarita, Martín-Martín, Andres, Obeso, Miriam, López-Mata, Inigo Royo, Crespo, Lira, Pelari-Mici, O, Juan Vidal, Xabier, Mielgo-Rubio, Juan Carlos, Trujillo-Reyes, Felipe, Couñago
Publikováno v:
Scientia
Non-small cell lung cancer; Oligometastatic Cáncer de pulmón de células no pequeñas; Oligometastásico Càncer de pulmó de cèl·lules no petites; Oligometastàtic The management of patients with advanced non-small cell lung carcinoma (NSCLC) ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d27fc45c02a936d7f54bb6dee73337c
https://hdl.handle.net/11351/8662
https://hdl.handle.net/11351/8662
Autor:
Niki Karachaliou, Rebecca J. Nagy, Rafael Rosell, François Riva, Enric Carcereny, Andrea Malfettone, Ernest Nadal, Santiago Viteri, Richard B. Lanman, Ramon Palmero, Enriqueta Felip, Miguel Sampayo, Javier Garde-Noguera, Álvaro Taus, Iris Faull, Daniel Dix, Margarita Majem
Publikováno v:
JCO Precision Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Purpose Treatment guidelines for advanced non–small-cell lung cancer (aNSCLC) recommend broad molecular profiling for targeted therapy selection. This study prospectively assessed comprehensive next-generation sequencing (NGS) of cell-free circulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c00fbd48d0312181689236aecbc3c8f0
https://pubmed.ncbi.nlm.nih.gov/34994593
https://pubmed.ncbi.nlm.nih.gov/34994593
Autor:
Nuria Piera-Molons, Antonio Llombart-Cussac, Jose García-Sánchez, Beatriz Honrubia-Peris, Javier Garde-Noguera, Maria L. Fernández-Murga
Publikováno v:
Cancers
Cancers, Vol 13, Iss 4280, p 4280 (2021)
Cancers, Vol 13, Iss 4280, p 4280 (2021)
Simple Summary Immunotherapy, most notably immune checkpoint inhibitors (ICIs), has revolutionized the treatment of advanced non-small cell lung cancer (NSCLC). Although some patients respond well to ICIs, many patients do not benefit from ICIs, lead
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4361ffae2ba94c7330dc4819c40448a7
https://pubmed.ncbi.nlm.nih.gov/34503087
https://pubmed.ncbi.nlm.nih.gov/34503087
Autor:
Carmen Beato, Antoni Gelabert, Sonia Maciá, Jose Angel Arranz, Begoña Perez-Valderrama, Javier Garde-Noguera, Juan Antonio Virizuela, Albert Font, Sergio Vázquez, Gustavo Rubio, Enrique Gallardo, Alvaro Pinto, Raquel Luque, Montse Domenech, E. Fernández-Parra, Enrique Grande, Javier Puente, Jose Carlos Villa, Ovidio Fernandez Calvo, Rafael Morales-Barrera, Xavier Maldonado
Publikováno v:
Targeted Oncology. 14:15-32
Bladder cancer is the fourth most common cancer in men and the ninth most common in women in the Western world. The management of bladder carcinoma requires a multidisciplinary approach. Optimal treatment depends on several factors, including histolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c23f695680f8a733ced1d64070b203a
https://doi.org/10.1007/s11523-019-00619-7
https://doi.org/10.1007/s11523-019-00619-7
Autor:
María Leonor Fernandez-Murga, Lucia Serrano-Garcia, Javier Garde-Noguera, Maria Portero, José García-Sánchez, Lorena Regal, Victoria Dominguez-Martinez, Antonio Llombart-Cussac
Publikováno v:
Journal of Clinical Oncology. 40:e13632-e13632
e13632 Background: Coranavirus disease 2019 (COVID-19) has affected more than 220 millon people worldwide. The establishment of safe and effective vaccine coverage is crucial in these patients. We aim to investigate the safety, adverse effects and im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a8146afd97222b64966784da7d66fd3
https://doi.org/10.1200/jco.2022.40.16_suppl.e13632
https://doi.org/10.1200/jco.2022.40.16_suppl.e13632
Autor:
Victoria Dominguez-Márquez, M Leonor Fernández-Murga, Javier Garde-Noguera, Nuria Piera, Franscica López Chuliá, Vicent Giner-Bosch, Antonio Llombart-Cussac, Jose Garcia Sanchez, Juan José Soler-Cataluña, Beatriz Honrubia
Publikováno v:
Cancers
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
instname
Cancers, Vol 12, Iss 3513, p 3513 (2020)
CEU Repositorio Institucional
Fundación Universitaria San Pablo CEU (FUSPCEU)
Volume 12
Issue 12
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
instname
Cancers, Vol 12, Iss 3513, p 3513 (2020)
CEU Repositorio Institucional
Fundación Universitaria San Pablo CEU (FUSPCEU)
Volume 12
Issue 12
Background: Studies of patients with cancer affected by coronavirus disease 2019 (COVID-19) are needed to assess the impact of the disease in this sensitive population, and the influence of different cancer treatments on the COVID-19 infection and se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc3698d2bd5d57d89416ac02db62a244
https://pubmed.ncbi.nlm.nih.gov/33255856
https://pubmed.ncbi.nlm.nih.gov/33255856
Autor:
Federico Rojo, David Vicente, Carlos Aguado, Xabier Mielgo-Rubio, Amadeo Wals, Laura Mezquita-Pérez, Manel Juan, Felipe Couñago, Javier Garde-Noguera, Francesc Casas
Publikováno v:
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
World Journal of Clinical Oncology
Universidad Europea (UEM)
World Journal of Clinical Oncology
After publication of the PACIFIC trial results, immune checkpoint inhibitor-based immunotherapy was included in the treatment algorithm of locally advanced non-small cell lung cancer (NSCLC). The PACIFIC trial demonstrated that 12 mo of durvalumab co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5da8b16e582f8ca30757943dc12eb79
http://hdl.handle.net/11268/10623
http://hdl.handle.net/11268/10623
Publikováno v:
World Journal of Clinical Oncology
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
The European Organization for Research on Treatment of Cancer Research published a consensus statement to establish the key criteria to define oligometastatic disease (OMD). According to those criteria, all lesions (both primary and metastatic) shoul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77c8c8dd402c7a8cc61e0179df497fbe
https://hdl.handle.net/11268/11195
https://hdl.handle.net/11268/11195
Autor:
Nuria Piera, Marta Benet, Lourdes Cordón, José García-Sánchez, Javier Garde-Noguera, M. A. de la Casa de Julian, L. Gonzalez-Castillo, Alfredo Sanchez-Hernandez, Agustín Lahoz, Julian Carretero, M.C. Gomez-Soler, V. Ruiz, David Lorente, Marta Piqueras, O. Juan-Vidal
Publikováno v:
Journal of Thoracic Oncology. 16:S788-S789
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea4aee5c06f82009a29df8b5048891a3
https://doi.org/10.1016/s1556-0864(21)02007-4
https://doi.org/10.1016/s1556-0864(21)02007-4